AGENDA

Thursday, May 30, 2019

8:15 - 8:20 AM
Welcome
Alfonso Torquati, MD
8:20 - 8:30 AM
Opening Statement
Mia Levy, MD, PhD
8:30 - 12:15 PM

MORNING SESSION: COLORECTAL LIVER METASTASES

Co-Chairs: Mark S. Talamonti, MD; Erik Schadde, MD
8:30 - 9:00 AM
Colorectal Liver Metastases: What is the evidence in 2019?
Michael D’Angelica, MD
9:00 - 9:30 AM
NCCN Guidelines: Conversion/Cytoreduction Therapy for Colorectal Liver Metastases with Intent to Cure. Who is a Candidate in 2019?
Al Benson, MD
9:30 - 10:00 AM
What Are the Surgical Limitations of Resecting Colorectal Liver Metastases in 2019?
Claudius Conrad, MD, PhD
10:00 - 10:15 AM
Coffee Break
10:15 - 10:45 AM
What Molecular Subtyping Defines a Curable Oligometastatic State in Colorectal Liver Metastases?
Ralph R. Weichselbaum, MD
10:45 - 11:00 AM
15 Minute Update: 3-finger toxins - Roles for normal and cancerous tissues
Jochen Reiser, MD, PhD
11:00 - 11:30 AM
Colorectal Cancer - Liver AND Extrahepatic Colorectal Metastases: What to do?
Kiran Turaga, MD, MPH
11:30 - 11:45 AM
Panel Discussion: Colorectal Liver Metastases
Al Benson, MD
Claudius Conrad, MD, PhD
Michael D’Angelica, MD
Riad Salem, MD
Kiran Turaga, MD, MPH
Ralph R. Weichselbaum, MD
11:45 - 12:15 PM
Case Presentations to the Panel: Presentation of Two Cases of Colorectal Liver Metastases
Ashiq Masood, MD
Audrey E. Kam, MD
12:15 - 1:30 PM
Lunch
1:30 - 5:30 PM

AFTERNOON SESSION: NON-COLORECTAL AND TECHNICAL CONSIDERATIONS

Co-Chairs: James Thomas, MD, Sam G. Pappas, MD
1:30 - 2:00 PM
Neuroendocrine Liver Metastases: When is Transplant an Option
Allan J. Koffron, MD
2:00 - 2:30 PM
What Are the Technical and Oncological Limitations of Liver Resection for Stage IV Neuroendocrine Tumors?
Xavier Keutgen, MD
2:30 - 3:00 PM
Which Liver Metastases Should be Primarily Considered for Ablation?
Bulent Arslan, MD
3:00 - 3:15 PM
Coffee Break
3:15 - 3:45 PM
Yttrium90 for Colorectal Liver Metastases: What is its role in 2019?
Riad Salem, MD
3:45 - 4:15 PM
Which Resections for Metastatic Liver Disease Can Be Done Laparoscopically?
Choon Hyuck David Kwon, MD, PhD
4:15 - 4:45 PM
Is Robotics the Future of Liver Surgery for Metastatic Disease?
Pier C. Giulianotti, MD
4:45 - 5:00 PM
Panel Discussion: Technical Difficulties in the Treatment of Liver Metastases
Rene Adam, MD
Bulent Arslan, MD
Pier C. Giulianotti, MD
Choon Hyuck David Kwon, MD, PhD
Xavier Keutgen, MD
Allan J. Koffron, MD
5:00 - 5:30 PM
Case Presentations to the Panel: Presentation of Two Cases of Non-Colorectal Liver Metastases
Xavier Keutgen, MD
Kiran Turaga, MD, MPH
5:30 - 5:45 PM
Summary and Concluding Remarks
Sam G. Pappas, MD, FACS



Copyright © All Rights Reserved
Privacy Policy
203-263-0006